The success of Sildenafil initially fueled a surge for pharma, however recent shifts present a uncertain outlook for those considering a stake. Off-patent competitors are eroding earnings, and continued legal battles https://lexienpic373221.blazingblog.com/41218908/sildenafil-and-the-pharmaceutical-industry-a-risky-bet